Asymptomatic HIV testing in Castelnuovo di Porto

Find health labs to test for Asymptomatic HIV in Castelnuovo di Porto and compare all offers by prices and services.

Tests that cover Asymptomatic HIV

HIV Test
test epatite B, epatite C, HIV con autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€60.00

€57.00 with our promocode

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Giuseppe Di Vittorio, 3 00067 Morlupo (Roma)

1.2 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Bachelet, 32 00065 Fiano Romano (RM)

5.7 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Castelli 1 00060 Formello (RM)

6 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Nazario Sauro 46 F 00060 Formello (RM)

6 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Salaria, 164 00015 Monterotondo (RM)

7.9 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via della Stazione di Cesano, 576 00123 Cesano (RM)

16.1 km

Unverified

See Details

Rapid HIV Test by Filia Studio Patologia Clinica

Via Costantiniana, 28, 00188 Roma RM, Italia

16.1 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Luigi Einaudi, 33 00013 Mentana (Roma)

9.5 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Anton Giulio Bragaglia, 78 E/F 00123 Olgiata (RM)

16.1 km

Unverified

See Details

Rapid HIV Test by Eurofins Genoma

Via di Castel Giubileo, 11, 00138 Roma RM, Italia

16.1 km

Unverified

See Details

Asymptomatic HIV - symptoms and how to test

The second stage of HIV/AIDS involves infection without symptoms. At this time, HIV infection shows no visible symptoms. Patients often seek medical treatment due to symptoms; therefore, asymptomatic infections frequently go undetected. According to an estimate, around 10-60 % of individuals with early HIV infection will not experience symptoms. Patients who are asymptomatic but have HIV infection might benefit from therapies to lower their risk of clinical events and disease transmission if tested and found to have the virus.